中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
MeSH:(Glaucoma, Neovascular/*drug therapy/*etiology)

1.A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab.

Jongseok PARK ; Hoyoung LEE ; Young Kook KIM ; Jeong Don CHAE ; Hyun Joo LEE

Korean Journal of Ophthalmology 2011;25(5):362-365

2.Intravitreal Bevacizumab for the Treatment of Neovascular Glaucoma Associated With Central Retinal Artery Occlusion.

Min SAGONG ; Jinseon KIM ; Woohyok CHANG

Korean Journal of Ophthalmology 2009;23(3):215-218

3.Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series.

Jin Young CHOI ; Jaewan CHOI ; Yeon Deok KIM

Korean Journal of Ophthalmology 2010;24(1):47-52

4.Progression of Impending Central Retinal Vein Occlusion to the Ischemic Variant Following Intravitreal Bevacizumab.

Na Rae KIM ; Hee Seung CHIN

Korean Journal of Ophthalmology 2010;24(3):179-181

5.Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome.

Sang Joon LEE ; Jung Joo LEE ; Soo Young KIM ; Shin Dong KIM

Korean Journal of Ophthalmology 2009;23(2):132-134

6.Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome.

Sang Joon LEE ; Jung Joo LEE ; Soo Young KIM ; Shin Dong KIM

Korean Journal of Ophthalmology 2009;23(2):132-134

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO